Financial Data and Key Metrics Changes - The company reported total revenue of $382.5 million, up 13% year over year on a GAAP basis and up 12.5% year over year on a constant currency basis [7][9] - Non-GAAP operating margin increased nearly 109 basis points year over year to 21.2%, representing the highest performance in the company's history as a public company [9] - Non-GAAP EPS grew by 10%, exceeding expectations, and free cash flow increased by 20% year over year to $70 million [9][34] Business Line Data and Key Metrics Changes - Cardiovascular segment sales grew by 10% and endoscopy segment sales increased by 81% [26] - Cardiac intervention product sales rose by 23%, with organic growth of approximately 10% [27] - Peripheral intervention products and custom procedure solutions saw sales increases of 6% and 4%, respectively [28] Market Data and Key Metrics Changes - U.S. sales increased by 17% on a constant currency basis, while international sales grew by 7% year over year [30] - Sales in China decreased by 6%, attributed to the broader macro environment [31][75] - The company expects low double-digit growth in EMEA and mid-teens growth in the Rest of the World region, with approximately 2% growth in the APAC region [37] Company Strategy and Development Direction - The company announced the acquisition of BioLife Delaware LLC for $120 million, aimed at enhancing its product offerings in hemostatic solutions [10][11] - A comprehensive marketing plan for the Rhapsody CIE was launched, focusing on raising awareness and expanding physician relationships [14] - The pricing strategy for Rhapsody CIE is based on a premium price relative to competitors, supported by clinical evidence demonstrating its efficacy [16][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver strong execution and revenue growth despite a dynamic global macro environment [10] - The company acknowledged a two-quarter delay in securing add-on reimbursement for the outpatient setting but maintained long-term growth expectations for Rhapsody CIE [24][39] - Management emphasized the importance of their reimbursement strategy and ongoing engagement with CMS to secure necessary approvals [23][49] Other Important Information - The company updated its 2025 financial guidance, expecting GAAP net revenue growth of 10% to 11% and non-GAAP diluted EPS in the range of $3.52 to $3.72 [36][40] - The anticipated impact of tariffs on the cost of goods is expected to be significantly lower than previously forecasted [41][42] Q&A Session Summary Question: Clarification on Rhapsody reimbursement process - Management clarified that they applied for a new technology APC assignment but did not receive it, and they plan to submit for TPT by September 1 [49][50] Question: Confidence in securing TPT - Management expressed high confidence in meeting TPT guidelines and emphasized the strength of their product and data [62] Question: Sales performance in cardiac intervention - Management attributed the growth to internal product development and the strategic acquisition of Cook Medical, expecting continued strong performance [94][96]

Core Viewpoint - The Federal Reserve has maintained the interest rate at 4.25%-4.50%, marking the fifth consecutive meeting without changes, aligning with market expectations [5][6]. Summary by Sections Interest Rate Decision - The Federal Reserve decided to keep the benchmark interest rate unchanged at 4.25%-4.50%, consistent with market predictions [5]. - This decision reflects a cautious approach amid economic uncertainties and inflation concerns [6]. Voting Discrepancies - There was a notable dissent among the board members, with Governors Waller and Bowman advocating for a rate cut, marking the first time in over 30 years that two members voted against the majority [5][6]. Inflation Outlook - The Fed did not alter its inflation language, indicating that inflation remains somewhat elevated [6]. - Core PCE inflation is projected to rise by 2.7% year-on-year, while overall PCE is expected to increase by 2.5% [6]. Economic Outlook - Economic growth has slowed in the first half of the year, and uncertainty regarding future economic conditions remains high [6]. - The Fed's current policy stance is viewed as favorable, but decisions regarding future meetings will depend on incoming data [6][10]. Market Reactions - Analysts suggest that the Fed may resume a loosening cycle in the fall if inflation pressures from tariffs are confirmed to be temporary [10]. - The market is closely monitoring the Fed's stance, with expectations of potential rate cuts depending on economic data trends [10][13].

财料 联邦基金利率变化值(%) 0.9 0.6 0.3 0 -0.3 -0.6 -0.9 -1.2 2018 2018 2019 2020 2020 2021 2022 2023 2023 2024 2025 02 | 声明关键内容 连续5次按兵不动，但美联储内部裂痕加深。特朗普说9月降息，是剧透还是预言？至少现在市场预计今年再降息还有希望…… 一图读懂美联储7月利率决议 l /0 0% 2018 2019 2020 2020 2021 2022 2023 2023 2024 2025 2018 01 声明概述 维持基准利率在4.25%-4.50%不变,连续第五次按兵不 动,符合市场预期 02 投票分歧 理事沃勒、鲍曼主张降息,为30多年来首次有两位理事投下 反对票 03 通胀前景 未修改通胀措辞,表示通胀仍在一定程度上偏高 04 经济前景 上半年经济增长放缓,前景不确定性仍然居高 05 被总统"剧透" 在决议公布前10分钟,总统特朗普表示美联储此次不会降 息,并表示其会在9月降息 03 | 新闻发布会要点 01 利率前景 当前政策立场处于有利位置;尚未就9月会议作出任何决 定;无法在六周后依据6月点阵图来做 ...

福特汽车二季度调整后EBIT为21亿美元，分析师预期19.1亿美元。 预计美国总统特朗普关税将造成公司利润在2025年下滑36%。 福特汽车（F）美股盘后跌约3%。 ...

鲍威尔还提到，在关于政策的讨论中，多数观点认为，当前通胀高于目标水平，就业处于目标水平，因 此政策应保持一定的限制性。事实上，通胀距离目标比就业更远，劳动力市场是目前拥有的最佳经济数 据，从辞职率、职位空缺数和失业率等指标来看，就业市场仍然稳固，许多就业指标与一年前的情况类 似。但市场仍存在下行风险，在下次会议之前，还有两份就业和通胀报告。 新华财经北京7月31日电（郭洲洋）美联储联邦公开市场委员会（FOMC）会议后，美联储主席杰罗姆· 鲍威尔召开新闻发布会，就当前美国经济状况、货币政策调整及未来展望进行了详细阐述。 鲍威尔指出，尽管当前充满不确定性，美国经济仍然处于稳健状态。失业率保持在较低水平，劳动力市 场已达到或接近最大就业状态。他认为，当前的货币政策立场让美联储有充足准备，在面对未来可能的 经济变化时能及时应对。 关于通胀，鲍威尔表示，通胀虽然较2022年高点回落，但仍略高于2%的目标。目前存在"追赶性通 胀"，这反映了过去的压力，且无法将关税对通胀的影响单独剥离出来，同时服务业通胀正在下降，商 品通胀正在上升。他特别指出，关税开始在消费者价格中体现，核心通胀中有0.3至0.4个百分点是由关 税因素导 ...

美国总统特朗普：今天我们在白宫忙于处理贸易协议，我将于今天下午会见韩国贸易代表团。韩国目前 的关税是25%，但他们有降低关税的提议。 ...

1、货币政策 并没有针对9月FOMC货币政策会议做决定。 那些对7月美联储决议声明持异议的人将在未来一两天披露相关信息。 2、通胀 通胀朝着2%这一目标回落的过程已经过半。 服务通胀显著放慢，商品通胀正在上升。 5、去留问题 对于是否会在美联储主席任期届满之后继续担任理事，没有透露任何消息。 6、市场反应 并没有看到就业市场走弱。 4、关税 关税传导至价格的过程可能比之前预料的更慢。 判断特朗普关税对通胀的影响仍然太早。 当前所看到的仅仅是关税通胀的开端而已，预计后续发布的通胀数据将体现出更多的关税影响。 无法在通胀问题上单独划分出关税的影响。 某些公司将从特朗普关税中获益。 面临长期住房供应短缺问题，美国并没有建设足够多的住房。 3、就业 鲍威尔新闻发布会结束后，标普500指数跌0.35%，道指跌290点跌幅0.64%，纳指跌0.06%，半导体指数 涨0.54%，银行指数跌0.63%，罗素2000指数跌0.47%。 ...

鲍威尔：某些公司将从（特朗普）关税中获益。 ...

美联储主席鲍威尔：一些公司会利用关税。 ...

Core Viewpoint - Federal Reserve Chairman Jerome Powell stated that 30% to 40% of core inflation is attributed to tariffs [1] Group 1 - The impact of tariffs on inflation is significant, indicating that trade policies can influence economic conditions [1] - Powell's comments suggest that the current inflationary pressures may be partially driven by external factors related to trade [1]